Interpace Biosciences, Inc. Financial Ratios — IDXG Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-18.47	-53.65	-13.4	-61.11	-68.49	-85.16	-52.66	-45.93	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-10.02	-26.61	-6.19	-17.38	-12.37	-15.22	-25.62	-29.99	-64.69	-54.41	-35.53	-80.72	13.43	48.03	101.07
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-6.47	-36.16	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-40.33	- -
Gross Margin (%)	20.64	21.17	16.04	13.98	26.74	49.25	53.71	53.43	34.4	33.1	56.78	57.26	62.58	63.77	62.31
EBITDA Margin (%)	0.78	0.81	-0.01	-905.63	-273.88	-79.91	-51.61	-33.39	-80.19	-57.03	-1.18	-1.06	13.9	18.87	12.67
Operating Margin (%)	-1.15	-0.8	-0.98	-1,067.84	-327.21	-114.17	-74.83	-50.74	-98.87	-74.01	-17.4	-12.06	9.9	17.28	10.55
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	95.18	60.16	49.09
Pretax Margin (%)	-3	-19.91	-1.02	-1,254.82	-468.68	-65.51	-82.61	-58.01	-110.16	-80.71	-23.38	-18.33	5.7	14.81	9.74
Profit Margin (%)	-7.57	-20.12	-3.12	-1,090.43	-120.4	-63.68	-76.84	-58.02	-110.4	-81.64	-45.12	-68.97	4.88	14.28	63.46
Net Income to Common Margin (%)	-7.57	-20.12	-3.12	-1,090.43	-120.4	-63.68	-76.84	-58.02	-112.18	-81.64	-45.12	-68.97	4.88	13.29	63.46
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.75	0.06	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.58	- -	- -	- -	- -	-7.16	- -
Sustainable Growth Rate (%)	-18.47	-53.65	-13.4	-61.11	-68.49	-85.16	-52.66	-45.93	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	27	8	8	- -	- -	7	5	11	16	11	6	1
ST Debt	- -	- -	- -	- -	1	- -	- -	- -	2	1	1	3	5	5	- -
LT Debt	- -	- -	- -	27	7	8	- -	- -	6	4	10	13	6	1	1
Total Debt/EBITDA	- -	- -	- -	-2.03	-0.33	-0.76	- -	- -	-0.37	-0.26	-27.5	-47.61	2.01	0.66	0.24
Net Debt/EBITDA	-52.18	-51.5	3,803.25	-0.3	- -	-0.7	1.85	0.83	-0.03	0.15	-17.36	-26.14	1.05	0.32	-0.51
Total Debt/EBIT	- -	- -	- -	-1.73	-0.27	-0.53	- -	- -	-0.3	-0.2	-1.86	-4.19	2.82	0.72	0.29
Net Debt/EBIT	35.49	52.31	31.76	-0.26	- -	-0.49	1.28	0.55	-0.03	0.12	-1.17	-2.3	1.47	0.35	-0.61
EBITDA to Interest Expense	- -	- -	- -	-22.17	-6.97	-4.88	-18.95	-22.08	-44.14	-33.65	-0.38	-0.34	5.52	13.44	29.2
EBITDA-CapEx/Interest Expense	- -	- -	- -	-41.03	-7.07	-4.88	-19.02	-23.44	-44.44	-36.52	-0.72	-0.65	5.05	12.11	27.08
EBIT to Interest Expense	- -	- -	- -	-26.15	-8.33	-6.97	-27.47	-33.57	-54.42	-43.67	-5.54	-3.81	3.93	12.3	24.31
Interest Expense	- -	- -	- -	1	4	2	- -	- -	- -	1	1	1	1	1	- -
Common Equity/Total Assets	52.5	45.42	47.03	17.36	19.26	15.63	74.39	49.62	-8.69	-165.54	-231.49	-394.72	-423.44	-14.99	66.09
Long-Term Debt/Equity (%)	- -	- -	- -	134.95	55.48	121.08	- -	- -	25.77	- -	- -	- -	- -	- -	3.36
Long-Term Debt/Capital (%)	- -	- -	- -	57.44	33.74	54.77	- -	- -	19.42	-14.54	-31.43	-27.7	-12.89	32.51	3.19
Long-Term Debt/Total Assets (%)	- -	- -	- -	23.43	10.68	18.93	- -	- -	10.85	7.75	25.92	81.44	43.57	8	2.22
Total Debt/Equity (%)	- -	- -	- -	134.95	64.4	121.08	- -	- -	32.71	-16.31	-25.28	-25.51	-20.15	-264.14	5.29
Total Debt/Capital (%)	- -	- -	- -	57.44	39.17	54.77	- -	- -	24.65	-19.49	-33.84	-34.25	-25.24	160.92	5.02
Total Debt/Total Assets (%)	- -	- -	- -	23.43	12.4	18.93	- -	- -	13.77	10.39	27.91	100.7	85.33	39.59	3.5
Net Debt to Equity	-108.09	-148.14	-140.52	20.09	0.67	111.87	-38.12	-39.29	3.13	9.53	-15.96	-14.01	-10.52	-127.6	-11.2
Net Debt/Capital (%)	1,336.46	307.72	346.8	16.73	0.66	52.8	-61.61	-64.7	2.57	10.22	-19.7	-17.06	-12.22	129.89	-11.91
EBITDA	1	1	- -	-13	-26	-10	-8	-7	-19	-18	- -	- -	6	9	5
EBITDA-CapEx	1	- -	-2	-25	-26	-10	-8	-8	-20	-20	-1	-1	5	8	5
Operating Income (Loss)	-2	-1	-1	-16	-31	-15	-12	-11	-24	-24	-6	-4	4	8	4

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.4	1.45	1.46	0.69	0.36	0.04	1.88	0.7	0.13	0.15	0.17	0.34	0.31	0.14	0.49
Current Ratio	1.74	1.97	2	1.34	0.82	0.26	2.45	2.04	0.95	0.77	0.78	0.85	0.91	1.11	1.94
Quick Ratio	1.66	1.8	1.77	0.86	0.52	0.19	2.3	1.79	0.73	0.59	0.47	0.69	0.75	0.94	1.6
CFO/Avg Current Liab	0.04	-0.25	-0.1	-0.5	-0.7	-0.38	-1.25	-1.03	-1.46	-0.79	-0.51	-0.51	0.29	0.42	0.74
Common Equity/Total Assets	52.5	45.42	47.03	17.36	19.26	15.63	74.39	49.62	-8.69	-165.54	-231.49	-394.72	-423.44	-14.99	66.09
Long-Term Debt/Equity (%)	- -	- -	- -	134.95	55.48	121.08	- -	- -	25.77	- -	- -	- -	- -	- -	3.36
Long-Term Debt/Capital (%)	- -	- -	- -	57.44	33.74	54.77	- -	- -	19.42	-14.54	-31.43	-27.7	-12.89	32.51	3.19
Long-Term Debt/Total Assets (%)	- -	- -	- -	23.43	10.68	18.93	- -	- -	10.85	7.75	25.92	81.44	43.57	8	2.22
Total Debt/Equity (%)	- -	- -	- -	134.95	64.4	121.08	- -	- -	32.71	-16.31	-25.28	-25.51	-20.15	-264.14	5.29
Total Debt/Capital (%)	- -	- -	- -	57.44	39.17	54.77	- -	- -	24.65	-19.49	-33.84	-34.25	-25.24	160.92	5.02
Total Debt/Total Assets (%)	- -	- -	- -	23.43	12.4	18.93	- -	- -	13.77	10.39	27.91	100.7	85.33	39.59	3.5
CFO/Total Liabilities	3.69	-24.02	-9.6	-17.1	-36.29	-21.58	-111.17	-55.31	-63.51	-18.7	-10.78	-9.73	5.52	27.31	50.81
CFO/CapEx	5.79	-9.25	-1.93	-1.44	-56.21	- -	-526.31	-19.32	-144.71	-8.88	-24.63	-23.89	8.06	5.3	16.38
Altman's Z-Score	2.4	2.32	2.09	-3.16	-10.36	-40.06	-8.22	-11.31	-11.19	-13.36	-8.25	-21.93	-21.84	-16.78	-6.72

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	15.2	12.49	23.28	0.51	2.84	5.22	5.63	3.39	2.44	3.53	5.22	6.56	7.92	6.89	5.46
Days Sales Outstanding	24.01	29.22	15.68	710.56	128.52	69.95	64.82	107.69	149.35	103.46	69.99	55.62	46.09	52.98	66.88
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	17.41	11.18	9.95	13.28	12.22	13.95	12.56
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	20.96	32.65	36.68	27.48	29.86	26.17	29.07
Accounts Payable Turnover	33.71	26.58	44.03	0.58	3.71	3.42	5.42	14.06	6.14	4.75	4.45	11.56	11.55	10.61	10.98
Accounts Payable Turnover Days	10.83	13.73	8.29	627.81	98.3	106.79	67.39	25.95	59.43	76.83	82.07	31.59	31.6	34.42	33.25
Cash Conversion Cycle	13.18	15.49	7.39	82.75	30.21	-36.84	-2.57	81.74	110.89	59.27	24.6	51.52	44.35	44.73	62.7
Inventory to Cash Days	24.01	29.22	15.68	710.56	128.52	69.95	64.82	107.69	128.39	70.81	33.31	28.14	16.23	26.81	37.82
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	2	2	1	1	1	1	1
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	2	2	1	1	1	1	1
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	95	114	73	27	8	10	28	23	20	13	31	4	5	12	5
- Cash & Cash Equivalents	64	53	46	23	8	1	15	6	2	3	3	5	3	1	3
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	26	47	47	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	27	8	8	- -	- -	7	5	11	16	11	6	1
Enterprise Value	30	61	27	31	8	17	13	17	51	61	86	16	12	16	4
Total Capital	60	36	32	47	21	14	40	15	29	-24	-32	-47	-44	4	24
Total Debt/Capital (%)	- -	- -	- -	57.44	39.17	54.77	- -	- -	24.65	-19.49	-33.84	-34.25	-25.24	160.92	5.02
Total Debt / EV	- -	- -	- -	0.86	1.02	0.47	- -	- -	0.14	0.08	0.12	1.02	0.9	0.36	0.29
EV/Sales	0.19	0.48	0.19	21.32	0.87	1.29	0.83	0.77	2.09	1.89	2.59	0.49	0.31	0.35	0.11
EV/EBITDA	24.49	59.38	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.23	1.84	0.84
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.13	2.01	1.01
EV/Cash Flow to Firm	15.21	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.59	3.07	0.59
EV/Free Cash Flow to Firm	12.97	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.36	2.64	0.57
Diluted Market Cap	93	111	71	27	7	8	16	23	19	13	31	4	5	42	34
Diluted Enterprise Value	28	58	25	31	7	15	1	16	50	61	85	16	12	47	33
EV per Share	1,023.96	2,033.44	897.3	1,023.12	231.96	387.86	23.7	29.43	64.47	75.5	102.41	18.31	14.24	18.48	4.66
TTM Sales	157	127	147	1	9	13	16	22	24	32	33	32	40	47	39
TTM EBITDA	1	1	- -	-13	-26	-10	-8	-7	-19	-18	- -	- -	6	9	5
TTM Operating Income	-2	-1	-1	-16	-31	-15	-12	-11	-24	-24	-6	-4	4	8	4
TTM Cash Flow to Firm	2	-10	-4	-16	-17	-6	-15	-8	-19	-13	-8	-7	5	5	7
TTM Free Cash Flow to Firm	2	-9	-2	-5	-17	-6	-15	-8	-18	-12	-7	-6	5	6	7

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	39.82	-12.08	-41.79	-5.31	-0.37	-1.05	-1.06	-2.74	-0.99	-1.02	-3.69	-0.6	1.11	7.69	5.51
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.13	2.01	1.01
Enterprise Value	30	61	27	31	8	17	13	17	51	61	86	16	12	16	4
Low Price	2,635	2,920	1,910	670	211	35	36	38.15	19.05	12.86	14.9	2.55	3.1	4.1	2.22
EV/Sales	0.19	0.48	0.19	21.32	0.87	1.29	0.83	0.77	2.09	1.89	2.59	0.49	0.31	0.35	0.11
EV/EBITDA	24.49	59.38	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.23	1.84	0.84
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.39	1.9	0.22
Price/Earnings Average	-9.15	-4.12	-17.29	-3.45	-2.08	-0.68	-2.55	-2.39	-1.07	-0.77	-2.11	-0.64	2.82	1.19	0.18
Price/Earnings High	-13.76	-5.07	-26.6	-5.79	-3.74	-4.32	-18.39	-3.95	-1.54	-1.68	-2.91	-1.64	7.82	2.49	0.49
Price/Earnings Low	-6.39	-3.34	-12.32	-1.24	-0.58	-0.15	-0.93	-1.69	-0.53	-0.39	-0.82	-0.1	1.37	0.58	0.08
Price/Book Value	1.59	3.19	2.25	1.37	0.63	1.47	0.71	1.49	-4.38	-0.17	-0.35	-0.07	-0.08	-5.37	0.24
Price/Book Value Average	1.87	3.03	2.5	2.84	2.06	1.03	1.38	2.01	-6.77	-0.27	-0.36	-0.22	-0.1	-3.35	0.2
Price/Book Value High	2.81	3.73	3.85	4.77	3.71	6.6	9.95	3.31	-9.77	-0.59	-0.5	-0.58	-0.28	-7.04	0.53
Price/Book Value Low	1.31	2.45	1.78	1.02	0.57	0.23	0.5	1.42	-3.33	-0.14	-0.14	-0.03	-0.05	-1.63	0.09
Price/Tangible Book Value	2.84	3.44	2.25	-0.64	-0.27	-0.32	4.2	7.89	-0.68	-0.13	-0.34	-0.07	-0.08	-5.37	0.24
Price/Tangible Book Value Average	3.34	3.26	2.5	-1.34	-0.88	-0.23	8.13	10.65	-1.05	-0.21	-0.35	-0.22	-0.1	-3.35	0.2
Price/Tangible Book Value High	5.02	4.01	3.85	-2.25	-1.59	-1.44	58.64	17.56	-1.52	-0.47	-0.48	-0.57	-0.28	-7.04	0.53
Price/Tangible Book Value Low	2.33	2.64	1.78	-0.48	-0.24	-0.05	2.96	7.53	-0.52	-0.11	-0.14	-0.03	-0.05	-1.63	0.09
Price/Sales	0.59	0.87	0.48	18.1	0.76	0.61	1.01	1.03	0.77	0.39	0.93	0.14	0.12	0.25	0.14
Price/Sales Average	0.69	0.83	0.54	37.59	2.5	0.43	1.96	1.39	1.2	0.63	0.95	0.44	0.14	0.16	0.11
Price/Sales High	1.04	1.02	0.83	63.18	4.5	2.75	14.13	2.29	1.73	1.37	1.31	1.13	0.38	0.33	0.31
Price/Sales Low	0.48	0.67	0.38	13.55	0.69	0.1	0.71	0.98	0.59	0.32	0.37	0.07	0.07	0.08	0.05
Price/Cash Flow	46.7	-10.78	-20.16	-1.63	-0.36	-1.05	-1.05	-2.6	-0.99	-0.91	-3.54	-0.57	1.23	2.55	0.93
Price/Cash Flow Average	54.93	-10.23	-22.47	-3.38	-1.19	-0.74	-2.04	-3.5	-1.53	-1.45	-3.62	-1.82	1.46	1.59	0.76
Price/Cash Flow High	82.57	-12.59	-34.57	-5.69	-2.14	-4.73	-14.72	-5.78	-2.2	-3.17	-4.98	-4.68	4.03	3.34	2.05
Price/Cash Flow Low	38.34	-8.28	-16.01	-1.22	-0.33	-0.17	-0.74	-2.48	-0.75	-0.74	-1.41	-0.28	0.71	0.77	0.34
Price/Free Cash Flow Average	46.84	-11.47	-46.58	-11.02	-1.21	-0.74	-2.04	-3.7	-1.54	-1.64	-3.77	-1.9	1.31	4.8	4.47
Price/Free Cash Flow High	70.4	-14.12	-71.68	-18.53	-2.18	-4.73	-14.75	-6.09	-2.22	-3.57	-5.2	-4.88	3.63	10.09	12.09
Price/Free Cash Flow Low	32.69	-9.28	-33.19	-3.97	-0.34	-0.17	-0.75	-2.61	-0.76	-0.84	-1.47	-0.29	0.64	2.34	1.99
EV/Sales Average	0.3	0.43	0.24	41.49	2.86	1.07	2.5	1.14	2.53	2.13	2.61	0.8	0.33	0.25	0.08
EV/Sales High	0.65	0.63	0.54	67.88	5.14	3.85	24	2.06	3.08	2.87	2.98	1.5	0.58	0.43	0.27
EV/Sales Low	0.08	0.27	0.08	16.71	0.8	0.67	0.3	0.72	1.89	1.82	2.03	0.42	0.26	0.17	0.02
EV/EBITDA Average	38.12	53.85	-2,974.19	-4.58	-1.04	-1.34	-4.85	-3.41	-3.15	-3.73	-222.04	-75.28	2.38	1.34	0.63
EV/EBITDA High	83.55	78.16	-6,625.78	-7.49	-1.88	-4.82	-46.49	-6.16	-3.85	-5.04	-253.03	-141.25	4.15	2.26	2.17
EV/EBITDA Low	10.84	33.77	-1,025.71	-1.84	-0.29	-0.84	-0.59	-2.16	-2.36	-3.19	-172.03	-39.81	1.87	0.9	0.13
EV/EBIT Average	-25.92	-54.7	-24.84	-3.89	-0.87	-0.94	-3.34	-2.24	-2.56	-2.88	-15.02	-6.63	3.34	1.46	0.76
EV/EBIT High	-56.82	-79.4	-55.33	-6.36	-1.57	-3.37	-32.07	-4.05	-3.12	-3.88	-17.12	-12.43	5.83	2.47	2.6
EV/EBIT Low	-7.37	-34.31	-8.57	-1.56	-0.24	-0.59	-0.41	-1.42	-1.92	-2.46	-11.64	-3.5	2.62	0.99	0.16
Last Price	3,210	3,800	2,405	895	232.5	220	51	40	25	15.7	37.35	5.2	5.4	13.5	6.15
High Price	5,675	4,440	4,125	3,125	1,370	990	712.5	89	55.79	55	52.55	42.45	17.7	17.7	13.5
Enterprise Value Average	47	55	36	61	27	14	40	25	61	69	87	25	13	12	3
Enterprise Value High	103	80	80	100	48	50	381	45	75	93	99	48	23	20	11
Enterprise Value Low	13	35	12	25	8	9	5	16	46	59	67	13	10	8	1

Shares Outstanding	- -	- -	- -	- -	- -	- -	1	1	1	1	1	1	1	1	1
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	1	1	1	1	1	1	3	6
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	1	1	1	1	1	1	1	1
Revenue per Share	5,446.36	4,350.33	4,978.05	49.46	304.65	360.27	50.42	38.88	32.33	40.21	40.04	37.56	46.37	53.48	43.77
EBITDA per Share	42.69	35.14	-0.41	-447.92	-834.37	-287.89	-26.02	-12.98	-25.92	-22.93	-0.47	-0.4	6.44	10.09	5.54
Operating Income per Share	-62.78	-34.59	-48.82	-528.15	-996.83	-411.32	-37.72	-19.73	-31.96	-29.76	-6.97	-4.53	4.59	9.24	4.62
Basic EPS, GAAP	-412.53	-875.11	-155.08	-539.33	-366.8	-229.41	-38.74	-22.56	-36.26	-32.83	-18.07	-25.91	2.26	7.11	27.77
Basic EPS from Cont Ops	-130.78	-873.09	-56.94	-451.85	-1,003.55	-231.55	-40.39	-22.59	-35.57	-32.52	-8.51	-6.92	2.62	7.92	28.24
Diluted EPS, GAAP	-412.53	-875.11	-155.08	-539.33	-366.8	-229.41	-38.74	-22.56	-36.26	-32.83	-18.07	-25.91	2.24	1.98	4.44
Diluted EPS from Cont Ops	-130.78	-873.09	-56.94	-451.85	-1,003.55	-231.55	-40.39	-22.59	-35.57	-32.52	-8.51	-6.92	2.59	2.21	4.51
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	68.73	-352.62	-119.31	-549.56	-640.89	-209.44	-48.4	-15.4	-25.3	-17.35	-10.54	-9.08	4.39	5.3	6.59
Free Cash Flow per Basic Share	56.86	-390.74	-181.07	-930.44	-652.29	-209.44	-48.5	-16.2	-25.48	-19.3	-10.97	-9.45	3.84	4.3	6.19
Cash & Equivalents per Share	2,186.04	1,766.56	1,507.7	755.75	238.24	13.83	27.3	10.57	2.96	3.42	3.18	5.62	4.02	1.66	2.83
Book Value per Share	2,018.48	1,190.4	1,070.54	654.97	369.09	150.05	71.61	26.91	-5.71	-93.23	-106.01	-73.4	-63.82	-2.51	25.25
Tangible Book Value per Share	1,129.44	1,106.11	1,070.54	-1,390.76	-862.11	-685.28	12.15	5.07	-36.68	-117.62	-108.55	-74.4	-63.82	-2.51	25.25

Interpace Biosciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)